Swiss National Bank Has $1.99 Million Holdings in The Beauty Health Company (NASDAQ:SKIN)

Swiss National Bank increased its position in shares of The Beauty Health Company (NASDAQ:SKIN – Get Rating) by 2.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 218,600 shares of the company’s stock after acquiring an additional 4,300 shares during the period. Swiss National Bank owned about 0.17% of Beauty Health worth $1,989,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Beauty Health by 8.6% during the 3rd quarter. Vanguard Group Inc. now owns 10,514,288 shares of the company’s stock worth $123,964,000 after acquiring an additional 830,141 shares in the last quarter. BlackRock Inc. lifted its stake in Beauty Health by 5.8% in the 1st quarter. BlackRock Inc. now owns 7,778,389 shares of the company’s stock valued at $131,300,000 after purchasing an additional 423,084 shares during the last quarter. Invesco Ltd. lifted its stake in Beauty Health by 8.8% in the 1st quarter. Invesco Ltd. now owns 5,020,317 shares of the company’s stock valued at $84,742,000 after purchasing an additional 407,849 shares during the last quarter. Luxor Capital Group LP lifted its stake in Beauty Health by 9.9% in the 3rd quarter. Luxor Capital Group LP now owns 4,071,271 shares of the company’s stock valued at $48,000,000 after purchasing an additional 365,790 shares during the last quarter. Finally, Senvest Management LLC lifted its stake in Beauty Health by 24.3% in the 3rd quarter. Senvest Management LLC now owns 3,368,895 shares of the company’s stock valued at $39,719,000 after purchasing an additional 659,548 shares during the last quarter. Institutional investors and hedge funds own 78.37% of the company’s stock.

Analyst Upgrades and Downgrades

SKIN has been the subject of several research reports. DA Davidson increased their price objective on shares of Beauty Health from $32.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, March 1st. Cowen dropped their price target on shares of Beauty Health from $20.00 to $15.00 and set an “outperform” rating for the company in a research note on Thursday, February 16th. Benchmark reaffirmed a “buy” rating and set a $23.00 price target on shares of Beauty Health in a research note on Tuesday, March 14th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $18.00 price target on shares of Beauty Health in a research note on Tuesday, March 28th. Finally, BNP Paribas upgraded shares of Beauty Health from an “underperform” rating to a “neutral” rating in a research report on Monday, March 20th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $19.50.

Beauty Health Trading Up 1.3 %

Shares of SKIN stock opened at $9.67 on Friday. The Beauty Health Company has a 52-week low of $8.25 and a 52-week high of $16.02. The company has a debt-to-equity ratio of 4.98, a quick ratio of 8.66 and a current ratio of 10.35. The company has a 50-day simple moving average of $11.65 and a two-hundred day simple moving average of $11.10. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of -43.95 and a beta of 1.12.

Beauty Health (NASDAQ:SKIN – Get Rating) last released its earnings results on Tuesday, February 28th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. The firm had revenue of $98.13 million for the quarter, compared to analysts’ expectations of $94.97 million. Beauty Health had a negative net margin of 2.77% and a negative return on equity of 3.57%. Research analysts anticipate that The Beauty Health Company will post 0.02 EPS for the current fiscal year.

Beauty Health Profile

(Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.